Sphere Fluidics develops single cell analysis & monoclonality assurance systems to enable leading-edge research & accelerate biotherapeutic discovery & development. Our picodroplet-based technology enables sensitive, rapid miniaturized assays of target protein secreted from tens of millions of individual cells. Our flagship product, Cyto-Mine®, integrates isolation, screening, sorting, imaging & dispensing into an automated platform to streamline workflows & capture high-value clones in a single run.